ALLO – allogene therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma [Yahoo! Finance]
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight [Yahoo! Finance]
Allogene Therapeutics Announces Q2 Investor Conference Participation
Form EFFECT Allogene Therapeutics,
Form 4 Allogene Therapeutics, For: Apr 22 Filed by: MOORE TIMOTHY L.
Form ARS Allogene Therapeutics, For: Dec 31
Form DEFA14A Allogene Therapeutics,
Form DEF 14A Allogene Therapeutics, For: Jun 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.